Lunit shares rose 18.65% in early KOSDAQ trading after Stockholm County in Sweden selected Lunit INSIGHT MMG for county-wide breast cancer screening. The AI mammography analysis software will be used at Capio St. Goran, Karolinska and Sodersjukhuset, with supply handled alongside Swedish medical imaging company Sectra. The agreement expands Lunit's province-level European sales push following contracts in Spain's Valencia region and Sweden's Dalarna County. Lunit said the Stockholm deployment follows clinical work at St. Goran Hospital, where researchers assessed about 55,000 screening cases from 2021 and 2022 and found that AI-assisted readings with one radiologist detected more cancers than readings by two radiologists. The company expects further European supply deals as the region's breast cancer screening market grows.